Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-25-058827
Filing Date
2025-04-25
Accepted
2025-04-25 16:49:09
Documents
22
Period of Report
2025-05-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A acad-20250425.htm   iXBRL DEF 14A 2659440
2 GRAPHIC img238125264_0.jpg GRAPHIC 11677
3 GRAPHIC img238125264_1.jpg GRAPHIC 11677
4 GRAPHIC img238125264_2.jpg GRAPHIC 5259
5 GRAPHIC img238125264_3.jpg GRAPHIC 1722534
6 GRAPHIC img238125264_4.jpg GRAPHIC 306146
7 GRAPHIC img238125264_5.jpg GRAPHIC 288541
8 GRAPHIC img238125264_6.jpg GRAPHIC 297450
9 GRAPHIC img238125264_7.jpg GRAPHIC 216589
10 GRAPHIC img238125264_8.jpg GRAPHIC 344981
  Complete submission text file 0000950170-25-058827.txt   11405764

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT acad-20250425.xsd EX-101.SCH 36514
24 EXTRACTED XBRL INSTANCE DOCUMENT acad-20250425_htm.xml XML 583363
Mailing Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130
Business Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-50768 | Film No.: 25874931
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)